| Feb 27, 2026 |
Mar 3, 2026 |
Pate R Carter
|
Director |
Sell |
20.0
|
-30,287
|
-72.27%
|
✗
|
$970.6K |
| Feb 27, 2026 |
Mar 3, 2026 |
Bavaro Michael
|
Chief Human Resources Officer |
Sell |
22.5
|
-6,000
|
-15.29%
|
✗
|
$198K |
| Feb 24, 2026 |
Feb 26, 2026 |
Whitworth Luke
|
COO |
Sell |
22.5
|
-4,605
|
-2.64%
|
✗
|
$155.7K |
| Feb 24, 2026 |
Feb 26, 2026 |
Grashoff Christopher L.
|
Chief Growth Officer |
Sell |
22.5
|
-1,980
|
-4.30%
|
✗
|
$67K |
| Feb 24, 2026 |
Feb 26, 2026 |
Smyser Collin
|
GC & Corporate Secretary |
Sell |
22.5
|
-2,210
|
-2.79%
|
✗
|
$74.7K |
| Feb 24, 2026 |
Feb 26, 2026 |
Adewunmi Femi
|
Chief Medical Officer |
Sell |
22.5
|
-1,627
|
-5.74%
|
✗
|
$55K |
| Feb 24, 2026 |
Feb 26, 2026 |
RADEMACHER JOHN CHARLES
|
CEO |
Sell |
20.0
|
-11,050
|
-1.59%
|
✗
|
$373.7K |
| Feb 24, 2026 |
Feb 26, 2026 |
Bavaro Michael
|
Chief Human Resources Officer |
Sell |
26.3
|
-1,354
|
-3.33%
|
✗
|
$45.8K |
| Feb 24, 2026 |
Feb 26, 2026 |
Maggio Nicole
|
Chief Accounting Officer |
Sell |
26.3
|
-975
|
-3.31%
|
✗
|
$33K |
| Feb 20, 2026 |
Feb 24, 2026 |
Bavaro Michael
|
Chief Human Resources Officer |
Sell |
20.0
|
-13,399
|
-24.81%
|
✗
|
$478.2K |
| Feb 20, 2026 |
Feb 24, 2026 |
Grashoff Christopher L.
|
Chief Growth Officer |
Sell |
22.5
|
-2,486
|
-5.12%
|
✗
|
$88.7K |
| Feb 20, 2026 |
Feb 24, 2026 |
Maggio Nicole
|
Chief Accounting Officer |
Sell |
26.3
|
-991
|
-3.25%
|
✗
|
$35.4K |
| Feb 20, 2026 |
Feb 24, 2026 |
Whitworth Luke
|
COO |
Sell |
17.5
|
-28,044
|
-13.87%
|
✗
|
$1M |
| Feb 20, 2026 |
Feb 24, 2026 |
RADEMACHER JOHN CHARLES
|
CEO |
Sell |
16.3
|
-148,442
|
-5.96%
|
✗
|
$5.3M |
| Feb 20, 2026 |
Feb 24, 2026 |
Smyser Collin
|
GC & Corporate Secretary |
Sell |
20.0
|
-17,445
|
-18.04%
|
✗
|
$622.6K |
| Feb 17, 2026 |
Feb 19, 2026 |
Whitworth Luke
|
COO |
Sell |
91.3
|
+29,915
|
17.36%
|
✗
|
$17.9K |
| Feb 17, 2026 |
Feb 19, 2026 |
Grashoff Christopher L.
|
Chief Growth Officer |
Sell |
90.0
|
+12,419
|
34.36%
|
✗
|
$9.1K |
| Feb 17, 2026 |
Feb 19, 2026 |
Bavaro Michael
|
Chief Human Resources Officer |
Sell |
91.3
|
+9,028
|
20.07%
|
✗
|
$19.4K |
| Feb 17, 2026 |
Feb 19, 2026 |
Maggio Nicole
|
Chief Accounting Officer |
Sell |
90.0
|
+3,979
|
15.03%
|
✗
|
$8.7K |
| Feb 18, 2026 |
Feb 19, 2026 |
RADEMACHER JOHN CHARLES
|
CEO |
Neutral |
90.0
|
+78,876
|
10.49%
|
✗
|
- |
| Feb 18, 2026 |
Feb 19, 2026 |
Adewunmi Femi
|
Chief Medical Officer |
Neutral |
90.0
|
+9,579
|
51.07%
|
✗
|
- |
| Feb 18, 2026 |
Feb 19, 2026 |
Sethna Meenal
|
CFO |
Neutral |
90.0
|
+27,045
|
49.11%
|
✗
|
- |
| Feb 18, 2026 |
Feb 19, 2026 |
Smyser Collin
|
GC & Corporate Secretary |
Neutral |
90.0
|
+15,213
|
18.67%
|
✗
|
- |
| Nov 3, 2025 |
Nov 4, 2025 |
KRAEMER HARRY M JANSEN JR
|
Director |
Buy |
97.5
|
+38,000
|
10.12%
|
✗
|
$987.4K |
| Oct 1, 2025 |
Oct 3, 2025 |
Sethna Meenal
|
CFO |
Neutral |
90.0
|
+55,067
|
100.00%
|
✗
|
- |
|
Oct 3, 2025 |
Sethna Meenal
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 9, 2025 |
Sep 10, 2025 |
Wright Norman L.
|
Director |
Buy |
95.0
|
+3,411
|
28.21%
|
✗
|
$100K |
| Aug 20, 2025 |
Aug 21, 2025 |
Pate R Carter
|
Director |
Buy |
78.8
|
+750
|
1.82%
|
✗
|
$20.4K |
| Aug 20, 2025 |
Aug 21, 2025 |
KRAEMER HARRY M JANSEN JR
|
Director |
Buy |
97.5
|
+36,000
|
10.61%
|
✗
|
$977.3K |
| Aug 21, 2025 |
Aug 21, 2025 |
SULLIVAN TIMOTHY P
|
Director |
Buy |
97.5
|
+20,000
|
68.43%
|
✗
|
$550.2K |
| Aug 21, 2025 |
Aug 21, 2025 |
GOLDING DAVID W
|
Director |
Buy |
68.8
|
+1,000
|
0.87%
|
✗
|
$27.6K |
| Aug 6, 2025 |
Aug 8, 2025 |
Maggio Nicole
|
Chief Accounting Officer |
Neutral |
90.0
|
+7,167
|
37.12%
|
✗
|
- |
| May 19, 2025 |
May 21, 2025 |
Smyser Collin
|
GC & Corporate Secretary |
Sell |
20.0
|
-10,713
|
-11.62%
|
✗
|
$354.5K |
| May 14, 2025 |
May 19, 2025 |
BETTEN ELIZABETH QUADROS
|
Director |
Neutral |
90.0
|
+5,034
|
20.82%
|
✗
|
- |
| May 14, 2025 |
May 19, 2025 |
Bierbower Elizabeth D
|
Director |
Neutral |
90.0
|
+5,034
|
26.72%
|
✗
|
- |
| May 14, 2025 |
May 19, 2025 |
Deckmann Natasha
|
Director |
Neutral |
90.0
|
+5,661
|
34.31%
|
✗
|
- |
| May 14, 2025 |
May 19, 2025 |
GOLDING DAVID W
|
Director |
Neutral |
85.0
|
+8,415
|
7.86%
|
✗
|
- |
| May 14, 2025 |
May 19, 2025 |
KRAEMER HARRY M JANSEN JR
|
Director |
Neutral |
82.5
|
+13,056
|
4.00%
|
✗
|
- |
| May 14, 2025 |
May 19, 2025 |
Pate R Carter
|
Director |
Neutral |
90.0
|
+5,034
|
13.93%
|
✗
|
- |
| May 14, 2025 |
May 19, 2025 |
SULLIVAN TIMOTHY P
|
Director |
Neutral |
90.0
|
+8,415
|
40.43%
|
✗
|
- |
| May 14, 2025 |
May 19, 2025 |
Bodem Barbara W.
|
Director |
Neutral |
90.0
|
+5,034
|
71.34%
|
✗
|
- |
| May 14, 2025 |
May 19, 2025 |
Wright Norman L.
|
Director |
Neutral |
90.0
|
+5,034
|
71.34%
|
✗
|
- |
| May 14, 2025 |
May 19, 2025 |
BRANDT ERIC
|
Director |
Neutral |
90.0
|
+5,034
|
94.54%
|
✗
|
- |
| Apr 22, 2025 |
Apr 24, 2025 |
Adewunmi Femi
|
Chief Medical Officer |
Sell |
26.3
|
-1,396
|
-6.93%
|
✗
|
$44K |
| Feb 28, 2025 |
Mar 3, 2025 |
Bavaro Michael
|
Chief Human Resources Officer |
Sell |
17.5
|
-30,996
|
-40.80%
|
✗
|
$1M |
| Feb 24, 2025 |
Feb 26, 2025 |
RADEMACHER JOHN CHARLES
|
CEO |
Neutral |
90.0
|
+74,814
|
11.04%
|
✗
|
- |
| Feb 24, 2025 |
Feb 26, 2025 |
Adewunmi Femi
|
Chief Medical Officer |
Neutral |
90.0
|
+10,287
|
104.26%
|
✗
|
- |
| Feb 24, 2025 |
Feb 26, 2025 |
Bavaro Michael
|
Chief Human Resources Officer |
Neutral |
90.0
|
+10,599
|
20.93%
|
✗
|
- |
| Feb 24, 2025 |
Feb 26, 2025 |
Grashoff Christopher L.
|
Chief Growth Officer |
Neutral |
90.0
|
+13,404
|
58.96%
|
✗
|
- |
| Feb 24, 2025 |
Feb 26, 2025 |
SHAPIRO MICHAEL H.
|
CFO |
Neutral |
90.0
|
+31,173
|
11.10%
|
✗
|
- |
| Feb 24, 2025 |
Feb 26, 2025 |
Smyser Collin
|
GC & Corporate Secretary |
Neutral |
90.0
|
+14,964
|
23.54%
|
✗
|
- |
| Feb 24, 2025 |
Feb 26, 2025 |
Whitworth Luke
|
COO |
Neutral |
90.0
|
+31,173
|
22.09%
|
✗
|
- |
| Feb 24, 2025 |
Feb 26, 2025 |
Maggio Nicole
|
Chief Accounting Officer |
Neutral |
90.0
|
+5,892
|
43.91%
|
✗
|
- |
| Feb 20, 2025 |
Feb 24, 2025 |
RADEMACHER JOHN CHARLES
|
CEO |
Sell |
17.5
|
-105,336
|
-2.86%
|
✗
|
$3.4M |
| Feb 20, 2025 |
Feb 24, 2025 |
Bavaro Michael
|
Chief Human Resources Officer |
Sell |
22.5
|
-1,840
|
-3.51%
|
✗
|
$59.3K |
| Feb 20, 2025 |
Feb 24, 2025 |
Maggio Nicole
|
Chief Accounting Officer |
Sell |
26.3
|
-1,128
|
-7.76%
|
✗
|
$36.3K |
| Feb 20, 2025 |
Feb 24, 2025 |
Whitworth Luke
|
COO |
Sell |
22.5
|
-6,146
|
-4.17%
|
✗
|
$198.2K |
| Feb 20, 2025 |
Feb 24, 2025 |
Grashoff Christopher L.
|
Chief Growth Officer |
Sell |
22.5
|
-2,406
|
-9.57%
|
✗
|
$77.6K |
| Feb 20, 2025 |
Feb 24, 2025 |
Smyser Collin
|
GC & Corporate Secretary |
Sell |
22.5
|
-2,003
|
-2.94%
|
✗
|
$64.6K |
| Feb 20, 2025 |
Feb 24, 2025 |
SHAPIRO MICHAEL H.
|
CFO |
Sell |
20.0
|
-9,355
|
-3.22%
|
✗
|
$301.5K |
| Feb 18, 2025 |
Feb 19, 2025 |
RADEMACHER JOHN CHARLES
|
CEO |
Neutral |
90.0
|
+157,830
|
25.71%
|
✗
|
- |
| Feb 18, 2025 |
Feb 19, 2025 |
Smyser Collin
|
GC & Corporate Secretary |
Neutral |
90.0
|
+23,676
|
53.35%
|
✗
|
- |
| Feb 17, 2025 |
Feb 19, 2025 |
Whitworth Luke
|
COO |
Sell |
95.0
|
+33,201
|
29.10%
|
✗
|
$242K |
| Feb 17, 2025 |
Feb 19, 2025 |
Bavaro Michael
|
Chief Human Resources Officer |
Sell |
95.0
|
+9,955
|
23.41%
|
✗
|
$228.5K |
| Feb 17, 2025 |
Feb 19, 2025 |
Grashoff Christopher L.
|
Chief Growth Officer |
Sell |
37.5
|
-223
|
-0.88%
|
✗
|
$7K |
| Feb 17, 2025 |
Feb 19, 2025 |
Maggio Nicole
|
Chief Accounting Officer |
Sell |
27.5
|
-172
|
-1.17%
|
✗
|
$5.4K |
| Feb 17, 2025 |
Feb 19, 2025 |
SHAPIRO MICHAEL H.
|
CFO |
Sell |
97.5
|
+29,628
|
11.37%
|
✗
|
$873.5K |
| Nov 8, 2024 |
Nov 13, 2024 |
KRAEMER HARRY M JANSEN JR
|
Director |
Buy |
97.5
|
+43,000
|
15.18%
|
✗
|
$969K |
| Oct 26, 2024 |
Oct 29, 2024 |
RADEMACHER JOHN CHARLES
|
CEO |
Sell |
20.0
|
-13,829
|
-2.20%
|
✗
|
$407.3K |
| Oct 21, 2024 |
Oct 23, 2024 |
Whitworth Luke
|
COO |
Sell |
22.5
|
-3,785
|
-3.21%
|
✗
|
$115.5K |
| Oct 21, 2024 |
Oct 23, 2024 |
Grashoff Christopher L.
|
Chief Growth Officer |
Sell |
26.3
|
-911
|
-3.47%
|
✗
|
$27.8K |
| Oct 21, 2024 |
Oct 23, 2024 |
Bavaro Michael
|
Chief Human Resources Officer |
Sell |
26.3
|
-911
|
-2.10%
|
✗
|
$27.8K |
| Oct 21, 2024 |
Oct 23, 2024 |
Maggio Nicole
|
Chief Accounting Officer |
Sell |
26.3
|
-342
|
-2.27%
|
✗
|
$10.4K |
| Oct 21, 2024 |
Oct 23, 2024 |
SHAPIRO MICHAEL H.
|
CFO |
Sell |
22.5
|
-7,570
|
-2.86%
|
✗
|
$231K |
| Sep 3, 2024 |
Sep 5, 2024 |
Pate R Carter
|
Director |
Sell |
26.3
|
-68,807
|
-65.57%
|
✗
|
$47.4K |
| Aug 22, 2024 |
Aug 23, 2024 |
SHAPIRO MICHAEL H.
|
CFO |
Sell |
20.0
|
-23,217
|
-8.58%
|
✗
|
$718.5K |
| Aug 21, 2024 |
Aug 22, 2024 |
BETTEN ELIZABETH QUADROS
|
Director |
Sell |
17.5
|
-47,531
|
-66.28%
|
✗
|
$1.5M |
| Aug 22, 2024 |
Aug 22, 2024 |
SULLIVAN TIMOTHY P
|
Director |
Sell |
17.5
|
-47,249
|
-69.42%
|
✗
|
$1.5M |
| Aug 15, 2024 |
Aug 19, 2024 |
Bavaro Michael
|
Chief Human Resources Officer |
Sell |
22.5
|
-5,765
|
-11.72%
|
✗
|
$181.1K |
|
Aug 9, 2024 |
Maggio Nicole
|
Chief Accounting Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 19, 2024 |
May 21, 2024 |
Grashoff Christopher L.
|
Chief Growth Officer |
Sell |
26.3
|
-1,522
|
-5.48%
|
✗
|
$45.3K |
| May 19, 2024 |
May 21, 2024 |
Smyser Collin
|
GC & Corporate Secretary |
Sell |
37.5
|
-238
|
-0.53%
|
✗
|
$7.1K |
| May 15, 2024 |
May 17, 2024 |
BRANDT ERIC
|
Director |
Neutral |
90.0
|
+5,325
|
100.00%
|
✗
|
- |
|
May 17, 2024 |
BRANDT ERIC
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 15, 2024 |
May 17, 2024 |
ARLOTTA JOHN
|
Director |
Neutral |
90.0
|
+9,150
|
14.79%
|
✗
|
- |
| May 15, 2024 |
May 17, 2024 |
BETTEN ELIZABETH QUADROS
|
Director |
Neutral |
85.0
|
+5,325
|
8.02%
|
✗
|
- |
| May 15, 2024 |
May 17, 2024 |
Bierbower Elizabeth D
|
Director |
Neutral |
90.0
|
+5,325
|
39.40%
|
✗
|
- |
| May 15, 2024 |
May 17, 2024 |
Deckmann Natasha
|
Director |
Neutral |
90.0
|
+5,985
|
56.92%
|
✗
|
- |
| May 15, 2024 |
May 17, 2024 |
GOLDING DAVID W
|
Director |
Neutral |
85.0
|
+6,219
|
6.16%
|
✗
|
- |
| May 15, 2024 |
May 17, 2024 |
KRAEMER HARRY M JANSEN JR
|
Director |
Neutral |
85.0
|
+13,806
|
5.12%
|
✗
|
- |
| May 15, 2024 |
May 17, 2024 |
Pate R Carter
|
Director |
Neutral |
85.0
|
+5,325
|
5.35%
|
✗
|
- |
| May 15, 2024 |
May 17, 2024 |
SULLIVAN TIMOTHY P
|
Director |
Neutral |
85.0
|
+5,325
|
8.49%
|
✗
|
- |
| May 15, 2024 |
May 17, 2024 |
Wright Norman L.
|
Director |
Neutral |
90.0
|
+5,325
|
307.63%
|
✗
|
- |
| May 15, 2024 |
May 17, 2024 |
Bodem Barbara W.
|
Director |
Neutral |
90.0
|
+5,325
|
307.63%
|
✗
|
- |
| Apr 22, 2024 |
May 10, 2024 |
Adewunmi Femi
|
Chief Medical Officer |
Neutral |
90.0
|
+9,867
|
100.00%
|
✗
|
- |
| May 9, 2024 |
May 10, 2024 |
Pate R Carter
|
Director |
Neutral |
27.5
|
-6,504
|
-6.13%
|
✗
|
- |
|
Apr 23, 2024 |
Adewunmi Femi
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 1, 2024 |
Apr 3, 2024 |
Bodem Barbara W.
|
Director |
Neutral |
90.0
|
+1,731
|
100.00%
|
✗
|
- |
| Apr 1, 2024 |
Apr 3, 2024 |
Wright Norman L.
|
Director |
Neutral |
90.0
|
+1,731
|
100.00%
|
✗
|
- |
| Mar 9, 2024 |
Mar 12, 2024 |
Whitworth Luke
|
COO |
Sell |
26.3
|
-1,373
|
-1.15%
|
✗
|
$44.4K |